CLINICAL_TRIALS
trial_result
· 2024-08-29
Clinical Trial Update: A Study to Prevent Rash in People Starting Alpelisib for the Treatment of Breast Cancer [Phase 2]
Summary
Phase 2 study to prevent rash in people starting alpelisib for breast cancer was terminated. Results were posted in 2024.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Memorial Sloan Kettering Cancer Center | Conditions: Breast Cancer | Phase 2 | Status: TERMINATED | Results posted: 2024-08-29